Docetaxel enhances apoptosis and G2/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma. [electronic resource]
Producer: 20161114ISSN:- 1676-5680
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Renal Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Docetaxel
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Gene Expression Regulation, Neoplastic
- Humans
- Kidney Neoplasms -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase 3 -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Taxoids -- pharmacology
- Xenograft Model Antitumor Assays
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.